glp-1 ulcerative colitis Medications: Reimagining the Treatment Paradigm for Severe Crohn's Disease Adjunctive GLP1 Receptor Agonists in

However, GLP-1 agonists are prescription-strength and require medical supervision to manage nausea, constipation, or other effects during dose escalation

It activates the AMPK pathway, a metabolic superstar that boosts the metabolism of fatty acids and glucose, leading to increased energy expenditure and fat reduction

Efficacy of Dula on colonic oxidative stress/inflammation: NF-B, IL-6, and IFN- expression levels Oxidative stress brought on by free radicals is necessary for the transcription factor NF-B to become activated when it is in its dormant state and combines with IB (Schreck et al

Mo1908: Glucagon-like peptide-1 receptor agonist use in patients with perianal fistulizing Crohn's disease is well tolerated and leads to weight loss and clinical improvement in fistula activity